Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ORAGENICS INC Director's Dealing 2015

Dec 17, 2015

35380_dirs_2015-12-17_16a71679-a1c4-47cf-a882-03c40714f5c7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAGENICS INC (OGEN)
CIK: 0001174940
Period of Report: 2015-12-15

Reporting Person: DUNTON ALAN W (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-12-15 Common Stock G 15100 $0.00 Disposed 92588 Direct

Footnotes

F1: Represents the aggregate amount of bona fide gifts made by Dr. Dunton.